ID   UBP11_HUMAN             Reviewed;         963 AA.
AC   P51784; B2RTX1; Q8IUG6; Q9BWE1;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   07-JUL-2009, sequence version 3.
DT   15-MAR-2017, entry version 169.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 11;
DE            EC=3.4.19.12 {ECO:0000269|PubMed:12084015, ECO:0000269|PubMed:24724799};
DE   AltName: Full=Deubiquitinating enzyme 11;
DE   AltName: Full=Ubiquitin thioesterase 11;
DE   AltName: Full=Ubiquitin-specific-processing protease 11;
GN   Name=USP11; Synonyms=UHX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 41-963, CATALYTIC ACTIVITY, SUBCELLULAR
RP   LOCATION, AND INTERACTION WITH RANBP9.
RC   TISSUE=Fetal brain;
RX   PubMed=12084015; DOI=10.1042/BJ20011851;
RA   Ideguchi H., Ueda A., Tanaka M., Yang J., Tsuji T., Ohno S.,
RA   Hagiwara E., Aoki A., Ishigatsubo Y.;
RT   "Structural and functional characterization of the USP11
RT   deubiquitinating enzyme, which interacts with the RanGTP-associated
RT   protein RanBPM.";
RL   Biochem. J. 367:87-95(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 52-963.
RC   TISSUE=Retina;
RX   PubMed=8845848; DOI=10.1093/hmg/5.4.533;
RA   Swanson D.A., Freund C.L., Ploder L., McInnes R.R., Valle D.;
RT   "A ubiquitin C-terminal hydrolase gene on the proximal short arm of
RT   the X chromosome: implications for X-linked retinal disorders.";
RL   Hum. Mol. Genet. 5:533-538(1996).
RN   [5]
RP   FUNCTION, INTERACTION WITH BRCA2, SUBCELLULAR LOCATION, MUTAGENESIS OF
RP   CYS-318, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15314155; DOI=10.1128/MCB.24.17.7444-7455.2004;
RA   Schoenfeld A.R., Apgar S., Dolios G., Wang R., Aaronson S.A.;
RT   "BRCA2 is ubiquitinated in vivo and interacts with USP11, a
RT   deubiquitinating enzyme that exhibits prosurvival function in the
RT   cellular response to DNA damage.";
RL   Mol. Cell. Biol. 24:7444-7455(2004).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH CHUK.
RX   PubMed=17897950; DOI=10.1074/jbc.M706282200;
RA   Yamaguchi T., Kimura J., Miki Y., Yoshida K.;
RT   "The deubiquitinating enzyme USP11 controls an IkappaB kinase alpha
RT   (IKKalpha)-p53 signaling pathway in response to tumor necrosis factor
RT   alpha (TNFalpha).";
RL   J. Biol. Chem. 282:33943-33948(2007).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH HUMAN PAPILLOMA VIRUS 16E7 (MICROBIAL
RP   INFECTION).
RX   PubMed=18408009; DOI=10.1074/jbc.M708278200;
RA   Lin C.H., Chang H.S., Yu W.C.;
RT   "USP11 stabilizes HPV-16E7 and further modulates the E7 biological
RT   activity.";
RL   J. Biol. Chem. 283:15681-15688(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-948, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-245, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   FUNCTION, INTERACTION WITH NFKBIA, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=19874889; DOI=10.1016/j.cellsig.2009.10.008;
RA   Sun W., Tan X., Shi Y., Xu G., Mao R., Gu X., Fan Y., Yu Y.,
RA   Burlingame S., Zhang H., Rednam S.P., Lu X., Zhang T., Fu S., Cao G.,
RA   Qin J., Yang J.;
RT   "USP11 negatively regulates TNFalpha-induced NF-kappaB activation by
RT   targeting on IkappaBalpha.";
RL   Cell. Signal. 22:386-394(2010).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH THE PRC1-LIKE
RP   COMPLEX.
RX   PubMed=20601937; DOI=10.1038/emboj.2010.129;
RA   Maertens G.N., El Messaoudi-Aubert S., Elderkin S., Hiom K.,
RA   Peters G.;
RT   "Ubiquitin-specific proteases 7 and 11 modulate Polycomb regulation of
RT   the INK4a tumour suppressor.";
RL   EMBO J. 29:2553-2565(2010).
RN   [13]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=20233726; DOI=10.1074/jbc.M110.104745;
RA   Wiltshire T.D., Lovejoy C.A., Wang T., Xia F., O'Connor M.J.,
RA   Cortez D.;
RT   "Sensitivity to poly(ADP-ribose) polymerase (PARP) inhibition
RT   identifies ubiquitin-specific peptidase 11 (USP11) as a regulator of
RT   DNA double-strand break repair.";
RL   J. Biol. Chem. 285:14565-14571(2010).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-648, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-648, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-948, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) OF 67-288, FUNCTION, CATALYTIC
RP   ACTIVITY, AND SUBUNIT.
RX   PubMed=24724799; DOI=10.1021/bi500116x;
RA   Harper S., Gratton H.E., Cornaciu I., Oberer M., Scott D.J.,
RA   Emsley J., Dreveny I.;
RT   "Structure and catalytic regulatory function of ubiquitin specific
RT   protease 11 N-terminal and ubiquitin-like domains.";
RL   Biochemistry 53:2966-2978(2014).
CC   -!- FUNCTION: Protease that can remove conjugated ubiquitin from
CC       target proteins and polyubiquitin chains (PubMed:12084015,
CC       PubMed:15314155, PubMed:17897950, PubMed:19874889,
CC       PubMed:20233726, PubMed:24724799). Inhibits the degradation of
CC       target proteins by the proteasome (PubMed:12084015). Cleaves
CC       preferentially 'Lys-6' and 'Lys-63'-linked ubiquitin chains. Has
CC       lower activity with 'Lys-11' and 'Lys-33'-linked ubiquitin chains,
CC       and extremely low activity with 'Lys-27', 'Lys-29' and 'Lys-48'-
CC       linked ubiquitin chains (in vitro) (PubMed:24724799). Plays a role
CC       in the regulation of pathways leading to NF-kappa-B activation
CC       (PubMed:17897950, PubMed:19874889). Plays a role in the regulation
CC       of DNA repair after double-stranded DNA breaks (PubMed:15314155,
CC       PubMed:20233726). Acts as a chromatin regulator via its
CC       association with the Polycomb group (PcG) multiprotein PRC1-like
CC       complex; may act by deubiquitinating components of the PRC1-like
CC       complex (PubMed:20601937). {ECO:0000269|PubMed:15314155,
CC       ECO:0000269|PubMed:17897950, ECO:0000269|PubMed:18408009,
CC       ECO:0000269|PubMed:19874889, ECO:0000269|PubMed:20233726,
CC       ECO:0000269|PubMed:24724799}.
CC   -!- CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester,
CC       thioester, amide, peptide and isopeptide bonds formed by the C-
CC       terminal Gly of ubiquitin (a 76-residue protein attached to
CC       proteins as an intracellular targeting signal).
CC       {ECO:0000269|PubMed:12084015, ECO:0000269|PubMed:24724799}.
CC   -!- SUBUNIT: Monomer (PubMed:24724799). Interacts with RANBP9/RANBPM
CC       (PubMed:12084015). Interacts with BRCA2 (PubMed:15314155).
CC       Interacts with CHUK/IKKA (PubMed:17897950). Interacts with NFKBIA
CC       (PubMed:19874889). Associated component of the Polycomb group
CC       (PcG) multiprotein PRC1-like complex (PubMed:20601937).
CC       {ECO:0000269|PubMed:12084015, ECO:0000269|PubMed:15314155,
CC       ECO:0000269|PubMed:17897950, ECO:0000269|PubMed:19874889,
CC       ECO:0000269|PubMed:24724799}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with papilloma virus
CC       protein 16E7 (PubMed:18408009). {ECO:0000269|PubMed:18408009}.
CC   -!- INTERACTION:
CC       P35226:BMI1; NbExp=7; IntAct=EBI-306876, EBI-2341576;
CC       Q9HC52:CBX8; NbExp=5; IntAct=EBI-306876, EBI-712912;
CC       P03129:E7 (xeno); NbExp=6; IntAct=EBI-306876, EBI-866453;
CC       Q9DLK6:NP (xeno); NbExp=3; IntAct=EBI-306876, EBI-8433218;
CC       P15659:PA (xeno); NbExp=2; IntAct=EBI-306876, EBI-8431752;
CC       P35227:PCGF2; NbExp=5; IntAct=EBI-306876, EBI-2129767;
CC       Q06587:RING1; NbExp=4; IntAct=EBI-306876, EBI-752313;
CC       Q99496:RNF2; NbExp=4; IntAct=EBI-306876, EBI-722416;
CC       P04608:tat (xeno); NbExp=3; IntAct=EBI-306876, EBI-6164389;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12084015,
CC       ECO:0000269|PubMed:15314155, ECO:0000269|PubMed:20233726}.
CC       Cytoplasm {ECO:0000269|PubMed:15314155}. Chromosome
CC       {ECO:0000269|PubMed:20233726, ECO:0000269|PubMed:20601937}.
CC       Note=Predominantly nuclear (PubMed:12084015, PubMed:15314155).
CC       Associates with chromatin (PubMed:20601937, PubMed:20233726).
CC       {ECO:0000269|PubMed:12084015, ECO:0000269|PubMed:15314155,
CC       ECO:0000269|PubMed:20233726, ECO:0000269|PubMed:20601937}.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-44 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC50450.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAC50450.1; Type=Frameshift; Positions=65, 117, 134, 146; Evidence={ECO:0000305};
CC       Sequence=BAC20463.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAD20056.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL096791; CAD20056.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC140849; AAI40850.1; -; mRNA.
DR   EMBL; BC000350; AAH00350.4; -; mRNA.
DR   EMBL; AB073597; BAC20463.1; ALT_INIT; mRNA.
DR   EMBL; U44839; AAC50450.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS14277.1; -.
DR   RefSeq; NP_004642.2; NM_004651.3.
DR   RefSeq; XP_005272731.1; XM_005272674.3.
DR   RefSeq; XP_011542290.1; XM_011543988.1.
DR   UniGene; Hs.171501; -.
DR   PDB; 4MEL; X-ray; 2.90 A; A/B=67-288.
DR   PDBsum; 4MEL; -.
DR   ProteinModelPortal; P51784; -.
DR   SMR; P51784; -.
DR   BioGrid; 113866; 137.
DR   DIP; DIP-27567N; -.
DR   IntAct; P51784; 101.
DR   MINT; MINT-1147600; -.
DR   STRING; 9606.ENSP00000218348; -.
DR   MEROPS; C19.014; -.
DR   iPTMnet; P51784; -.
DR   PhosphoSitePlus; P51784; -.
DR   BioMuta; USP11; -.
DR   DMDM; 251757432; -.
DR   EPD; P51784; -.
DR   MaxQB; P51784; -.
DR   PaxDb; P51784; -.
DR   PeptideAtlas; P51784; -.
DR   PRIDE; P51784; -.
DR   Ensembl; ENST00000218348; ENSP00000218348; ENSG00000102226.
DR   GeneID; 8237; -.
DR   KEGG; hsa:8237; -.
DR   UCSC; uc064yux.1; human.
DR   CTD; 8237; -.
DR   DisGeNET; 8237; -.
DR   GeneCards; USP11; -.
DR   HGNC; HGNC:12609; USP11.
DR   HPA; HPA003103; -.
DR   HPA; HPA037536; -.
DR   MIM; 300050; gene.
DR   neXtProt; NX_P51784; -.
DR   OpenTargets; ENSG00000102226; -.
DR   PharmGKB; PA37235; -.
DR   eggNOG; KOG1870; Eukaryota.
DR   eggNOG; COG5560; LUCA.
DR   GeneTree; ENSGT00670000097750; -.
DR   HOGENOM; HOG000264375; -.
DR   HOVERGEN; HBG000864; -.
DR   InParanoid; P51784; -.
DR   KO; K11835; -.
DR   OMA; NFRNPLG; -.
DR   OrthoDB; EOG091G0157; -.
DR   PhylomeDB; P51784; -.
DR   TreeFam; TF106276; -.
DR   Reactome; R-HSA-390471; Association of TriC/CCT with target proteins during biosynthesis.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   ChiTaRS; USP11; human.
DR   GeneWiki; USP11; -.
DR   GenomeRNAi; 8237; -.
DR   PRO; PR:P51784; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000102226; -.
DR   CleanEx; HS_USP11; -.
DR   ExpressionAtlas; P51784; baseline and differential.
DR   Genevisible; P51784; HS.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; TAS:ProtInc.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IDA:UniProtKB.
DR   GO; GO:0036459; F:thiol-dependent ubiquitinyl hydrolase activity; TAS:Reactome.
DR   GO; GO:0016579; P:protein deubiquitination; IDA:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   Gene3D; 3.30.2230.10; -; 1.
DR   InterPro; IPR006615; Pept_C19_DUSP.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR028135; Ub_USP-typ.
DR   InterPro; IPR029346; USP_C.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   Pfam; PF06337; DUSP; 1.
DR   Pfam; PF14836; Ubiquitin_3; 1.
DR   Pfam; PF00443; UCH; 1.
DR   Pfam; PF14533; USP7_C2; 1.
DR   SMART; SM00695; DUSP; 1.
DR   SUPFAM; SSF143791; SSF143791; 1.
DR   PROSITE; PS51283; DUSP; 1.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chromosome; Complete proteome; Cytoplasm;
KW   Hydrolase; Nucleus; Phosphoprotein; Protease; Reference proteome;
KW   Thiol protease; Ubl conjugation pathway.
FT   CHAIN         1    963       Ubiquitin carboxyl-terminal hydrolase 11.
FT                                /FTId=PRO_0000080632.
FT   DOMAIN       76    184       DUSP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00613}.
FT   DOMAIN      309    930       USP.
FT   ACT_SITE    318    318       Nucleophile.
FT   ACT_SITE    888    888       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10092, ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   MOD_RES     245    245       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     648    648       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     733    733       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q5D006}.
FT   MOD_RES     948    948       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:24275569}.
FT   MUTAGEN     318    318       C->S: Loss of deubiquitinase activity.
FT                                {ECO:0000269|PubMed:15314155}.
FT   CONFLICT     52     52       A -> AT (in Ref. 3; BAC20463).
FT                                {ECO:0000305}.
FT   CONFLICT     58     58       V -> M (in Ref. 4; AAC50450).
FT                                {ECO:0000305}.
FT   CONFLICT     62     62       A -> R (in Ref. 4; AAC50450).
FT                                {ECO:0000305}.
FT   CONFLICT     82     83       WR -> CG (in Ref. 4; AAC50450).
FT                                {ECO:0000305}.
FT   CONFLICT    160    160       A -> R (in Ref. 3; BAC20463).
FT                                {ECO:0000305}.
FT   CONFLICT    161    161       A -> R (in Ref. 3; BAC20463 and 4;
FT                                AAC50450). {ECO:0000305}.
FT   CONFLICT    489    489       P -> L (in Ref. 2; AAH00350).
FT                                {ECO:0000305}.
FT   HELIX        78     86       {ECO:0000244|PDB:4MEL}.
FT   STRAND       87     91       {ECO:0000244|PDB:4MEL}.
FT   STRAND      101    106       {ECO:0000244|PDB:4MEL}.
FT   HELIX       107    117       {ECO:0000244|PDB:4MEL}.
FT   TURN        118    120       {ECO:0000244|PDB:4MEL}.
FT   HELIX       134    136       {ECO:0000244|PDB:4MEL}.
FT   STRAND      140    142       {ECO:0000244|PDB:4MEL}.
FT   TURN        152    154       {ECO:0000244|PDB:4MEL}.
FT   STRAND      155    159       {ECO:0000244|PDB:4MEL}.
FT   HELIX       160    169       {ECO:0000244|PDB:4MEL}.
FT   STRAND      180    185       {ECO:0000244|PDB:4MEL}.
FT   STRAND      190    195       {ECO:0000244|PDB:4MEL}.
FT   STRAND      197    205       {ECO:0000244|PDB:4MEL}.
FT   STRAND      207    215       {ECO:0000244|PDB:4MEL}.
FT   HELIX       221    231       {ECO:0000244|PDB:4MEL}.
FT   STRAND      240    245       {ECO:0000244|PDB:4MEL}.
FT   TURN        247    249       {ECO:0000244|PDB:4MEL}.
FT   STRAND      252    254       {ECO:0000244|PDB:4MEL}.
FT   STRAND      257    261       {ECO:0000244|PDB:4MEL}.
FT   HELIX       262    264       {ECO:0000244|PDB:4MEL}.
FT   STRAND      271    276       {ECO:0000244|PDB:4MEL}.
SQ   SEQUENCE   963 AA;  109817 MW;  876FDC41945AFD9B CRC64;
     MAVAPRLFGG LCFRFRDQNP EVAVEGRLPI SHSCVGCRRE RTAMATVAAN PAAAAAAVAA
     AAAVTEDREP QHEELPGLDS QWRQIENGES GRERPLRAGE SWFLVEKHWY KQWEAYVQGG
     DQDSSTFPGC INNATLFQDE INWRLKEGLV EGEDYVLLPA AAWHYLVSWY GLEHGQPPIE
     RKVIELPNIQ KVEVYPVELL LVRHNDLGKS HTVQFSHTDS IGLVLRTARE RFLVEPQEDT
     RLWAKNSEGS LDRLYDTHIT VLDAALETGQ LIIMETRKKD GTWPSAQLHV MNNNMSEEDE
     DFKGQPGICG LTNLGNTCFM NSALQCLSNV PQLTEYFLNN CYLEELNFRN PLGMKGEIAE
     AYADLVKQAW SGHHRSIVPH VFKNKVGHFA SQFLGYQQHD SQELLSFLLD GLHEDLNRVK
     KKEYVELCDA AGRPDQEVAQ EAWQNHKRRN DSVIVDTFHG LFKSTLVCPD CGNVSVTFDP
     FCYLSVPLPI SHKRVLEVFF IPMDPRRKPE QHRLVVPKKG KISDLCVALS KHTGISPERM
     MVADVFSHRF YKLYQLEEPL SSILDRDDIF VYEVSGRIEA IEGSREDIVV PVYLRERTPA
     RDYNNSYYGL MLFGHPLLVS VPRDRFTWEG LYNVLMYRLS RYVTKPNSDD EDDGDEKEDD
     EEDKDDVPGP STGGSLRDPE PEQAGPSSGV TNRCPFLLDN CLGTSQWPPR RRRKQLFTLQ
     TVNSNGTSDR TTSPEEVHAQ PYIAIDWEPE MKKRYYDEVE AEGYVKHDCV GYVMKKAPVR
     LQECIELFTT VETLEKENPW YCPSCKQHQL ATKKLDLWML PEILIIHLKR FSYTKFSREK
     LDTLVEFPIR DLDFSEFVIQ PQNESNPELY KYDLIAVSNH YGGMRDGHYT TFACNKDSGQ
     WHYFDDNSVS PVNENQIESK AAYVLFYQRQ DVARRLLSPA GSSGAPASPA CSSPPSSEFM
     DVN
//
